Heart Disease Network Selects Mast Therapeutics’ AIR001 for Evaluation in Clinical Trial
The Heart Failure Clinical Research Network (HFN), a group of prestigious clinical centers located across North America, has selected Mast Therapeutics’ product AIR001 for evaluation in the Phase 2 clinical ... Read more